Press Articles

Biocon’s subsidiary Syngene’s shares drop 12% in 2022; here’s what management and analysts have to say

Business Today  | Rajesh Pherwani | September 30, 2022

Rajesh Pherwani talks about Syngene's contract research business

Article on Alkyl Amines in Business Today Magazine

Business Today  | Rajesh Pherwani | March 31, 2022

Excerpt of Rajesh Pherwani's views, on Alkyl Amines

Look what clicked for the PMSes that made big money since last Diwali

Economic Times  | Rajesh Pherwani | November 11, 2020

Economic Times coverage of Valcreate's leading performance

Six-month report cards show PMSes making dollops of money for ultra-HNIs

Economic Times  | Rajesh Pherwani | October 13, 2020

Economic Times coverage of Valcreate's leading performance

42 stocks from 2 sectors that doubled money in 2020 still have more steam

Economic Times  | Rajesh Pherwani | September 23, 2020

Economic Times coverage of Valcreate's leading performance

In one year until August 31, 3 of 4 PMSes beat Nifty index, says PMS Bazaar

CNBC TV18  | Rajesh Pherwani | September 23, 2020

CNBC TV18's coverage of Valcreate's leading performance

Three Fourths of PMS strategies beat returns of 2.8% by Nifty50 in August

Business Standard  | Rajesh Pherwani | September 12, 2020

Business Standard's coverage of Valcreate's leading performance

Pharma stocks have been the absolute darlings of the market for months now. But is all the good news in the price now? – Part 1

CNBC TV18  | Rajesh Pherwani | August 11, 2020

Rajesh Pherwani discusses the TINA factor causing strong upmove in pharma companies in the context of covid world.

Pharma stocks have been the absolute darlings of the market for months now. But is all the good news in the price now? – Part 2

CNBC TV18  | Rajesh Pherwani | August 11, 2020

Rajesh Pherwani discusses the TINA factor causing strong upmove in pharma companies in the context of covid world.

PMSes deliver over 50% return for Q1, but a few high-profile ones lag

Economic Times  | Rajesh Pherwani | July 14, 2020

Economic Times coverage of Valcreate's leading performance